Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for treatment of obsessive compulsive disorder
IRCT20241125063832N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pregabalin in obsessive compulsive disorder (OCD), sponsored by Arak University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20241125063832N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241125063832N1.